HeartCycle Project Sets Out to Create Innovative Telemonitoring Solutions

Clothes, bed sheets and home appliances could soon help heart patients to better deal with their condition. The new EU-funded HeartCycle project sets out to create innovative telemonitoring solutions. Launched on 1 March, it is one of the largest biomedical and healthcare research projects in the EU.

The system that the industry-led research consortium is planning to develop will improve the quality of care for coronary heart disease and heart failure patients by monitoring their condition at home, using unobtrusive sensors built into everyday objects. At the same time, the system is intended to report automatically to clinicians, so that they can adapt therapies and make lifestyle recommendations, as well as involve the patients themselves in the management of their disease. The latter is a great challenge as well as a great opportunity, according to Professor John Cleland, head of the Department of Cardiology at the University of Hull, UK. "Investing directly in people who need help, and not just in services that do things to or for them, makes sense in terms of improved care, greater affordability and the effective deployment of scarce nursing and medical resources," he says.

"By developing systems that remotely monitor heart patients and motivate them to adhere to treatment regimes and adopt beneficial lifestyles, we hope to improve the survival of people with heart disease as well as contain the overall cost of care," explains Henk van Houten, senior vice president of Phillips Research and head of the Healthcare Research programme.

"The development of such systems can only be achieved efficiently via multi-disciplinary partnerships between hardware engineers, software engineers, textile manufacturers, industrial designers, clinical experts and healthcare providers, as is the case in the HeartCycle project," Mr van Houten adds.

The public and private 18 project partners from Germany, Greece, Finland, Spain, Portugal, the Netherlands, the UK, Italy, Switzerland and China come from numerous different backgrounds in research, academia, medicine and industry. Over a period of four years, the EU will invest more than €14 million in the HeartCycle research under its Seventh Framework Programme (FP7). The total project cost amounts to nearly €22 million.

HeartCycle builds on the progress made by the MyHeart project, which will end in December 2008 and received funding under the Information Society Technologies (IST) programme of the Sixth Framework Programme (FP6). MyHeart, bringing together some of the same actors, developed advanced telemonitoring technologies and service concepts to enable people to play an active role in maintaining their health. It was during this research that the project partners identified home-based disease management as a potential field for improving medical standards of care, an objective that HeartCycle is trying to achieve with a focus on coronary heart disease.

A total of 1.9 million deaths in the EU every year are the result of cardiovascular diseases, causing annual health costs of €105 billion. Half of those deaths occur in people who have previously had a heart attack, which is why the project partners consider "finding better ways to manage and treat coronary heart disease and chronic heart failure as one of the most effective ways of reducing the human cost and financial burden of these debilitating conditions."

For further information, please visit:
http://www.research.philips.com/

Related news articles:

Copyright ©European Communities, 2008
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...